# Endometrial Response in Polycystic Ovarian Syndrome Treated With Letrozole Alone or With Added Estradiol Valerate

> **NCT07379502** · NA · NOT_YET_RECRUITING · sponsor: **CMH Kharian Medical College** · enrollment: 60 (estimated)

## Conditions studied

- PCOS (Polycystic Ovary Syndrome)

## Interventions

- **DRUG:** Letrozole (Aromatase Inhibitors)
- **DRUG:** Letrozole (Aromatase Inhibitors) + Estradiol valerate

## Key facts

- **NCT ID:** NCT07379502
- **Lead sponsor:** CMH Kharian Medical College
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-05
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-08-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07379502

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07379502, "Endometrial Response in Polycystic Ovarian Syndrome Treated With Letrozole Alone or With Added Estradiol Valerate". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07379502. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*